Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
ImmuPharma plc (IMM:LON) | 3.1 0 5.0% | Mkt Cap: 15.6m
Stanford Capital Research Team
16 pages
Companies: IMM SAR OBD CORO ESYS HAYD ENET MATD KIST
Companies: WJASEEPLI600258FARNCSRTAMSMEGPSYMDPHLGTEKFANCRIMMAGYTSTLCTHBOTBDOTDBVXPSCLPABCFULDNLVLGHZDVECSHOECAKESCSIDPTRCFISHJOULBDRXHCMHCHOF0NR1MXCTC4JMLM
Companies: ImmuPharma plc
Companies: TXG ETXPF NDVA/H TSVT BCOW Z29 TXG NCYT GNS SUN AMS OMG APH EKF EAH IMM AGL AGY TSTL IPO GDR TRX HVO CTEC OXB VLG IXI VAL INDV AGR AVCT 123F IMCR DTTYF DTXMF BCOW
